ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 22 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,000 | -98.5% | 3,092 | -97.7% | 0.00% | -100.0% |
| Q3 2019 | $520,000 | -5.8% | 132,603 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $552,000 | -40.2% | 131,022 | -2.6% | 0.00% | -50.0% |
| Q1 2019 | $923,000 | +84.2% | 134,542 | -1.1% | 0.00% | +100.0% |
| Q4 2018 | $501,000 | +21.6% | 136,072 | +109.0% | 0.00% | 0.0% |
| Q3 2018 | $412,000 | -20.6% | 65,092 | -5.0% | 0.00% | 0.0% |
| Q2 2018 | $519,000 | -10.2% | 68,522 | -5.2% | 0.00% | 0.0% |
| Q1 2018 | $578,000 | +0.2% | 72,302 | +40.3% | 0.00% | 0.0% |
| Q4 2017 | $577,000 | +25.2% | 51,551 | +29.7% | 0.00% | 0.0% |
| Q3 2017 | $461,000 | – | 39,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |